Praxis Precision Medicines (PRAX) Retained Earnings (2020 - 2026)

Praxis Precision Medicines' Retained Earnings history runs 7 years deep, the most recent figure standing at -$1.6 million for Q1 2026.

• On a quarterly basis, Retained Earnings fell 100.12% year-over-year to -$1.6 million in Q1 2026; TTM through Mar 2026 was -$1.6 million, a 100.12% decrease from a year earlier, with the FY2025 full-year figure at $563000.0, down 13.91% from the prior year.
• Retained Earnings eased to -$1.6 million in Q1 2026 per PRAX's latest filing, from $563000.0 in the prior quarter.
• Across five years, Retained Earnings topped out at $1.3 billion in Q1 2025 and bottomed at -$1.1 billion in Q3 2025.
• The 5-year median for Retained Earnings is -$515500.0 (2025), against an average of -$13.4 million.
• Biggest YoY gain for Retained Earnings was 293.89% in 2025; the steepest drop was 79070.47% in 2025.
• Year by year, Retained Earnings stood at $606.9 million in 2022, then rose by 19.22% to $723.6 million in 2023, then plunged by 99.91% to $654000.0 in 2024, then declined by 13.91% to $563000.0 in 2025, then sank by 383.13% to -$1.6 million in 2026.
• Per Business Quant, the three latest PRAX Retained Earnings figures stand at -$1.6 million (Q1 2026), $563000.0 (Q4 2025), and -$1.1 billion (Q3 2025).